Comparison of the effectiveness of surgical treatment of uterine fibroids (literature review)
- Authors: Kaptilnyy V.A.1, Poznyak M.V.1, Chilova R.A.1, Lystsev D.V.1, Svidinskaya E.A.1, Budnikova K.A.1, Proklova G.F.1, Manucheva T.G.1, Kokhreidze Z.M.1, Sevastyanov G.E.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
- Issue: Vol 35, No 12 (2024)
- Pages: 12-16
- Section: Topical Subject
- URL: https://journals.eco-vector.com/0236-3054/article/view/677645
- DOI: https://doi.org/10.29296/25877305-2024-12-02
- ID: 677645
Cite item
Abstract
In review describes the possibilities, advantages and disadvantages of various types of surgical treatment of uterine fibroids, based on the latest evidence-based medicine regarding their effectiveness and safety.
Full Text

About the authors
V. A. Kaptilnyy
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Author for correspondence.
Email: rtchilova@gmail.com
ORCID iD: 0000-0002-2656-132X
Associate Professor, Candidate of Medical Sciences
Russian FederationM. V. Poznyak
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: rtchilova@gmail.com
ORCID iD: 0009-0006-8217-0784
Russian Federation
R. A. Chilova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: rtchilova@gmail.com
ORCID iD: 0000-0001-6331-3109
Professor, MD
Russian FederationD. V. Lystsev
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: rtchilova@gmail.com
ORCID iD: 0009-0006-3826-3174
Russian Federation
E. A. Svidinskaya
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: rtchilova@gmail.com
ORCID iD: 0000-0002-2368-1932
Candidate of Medical Sciences
Russian FederationK. A. Budnikova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: rtchilova@gmail.com
ORCID iD: 0000-0003-3644-2292
Candidate of Medical Sciences
Russian FederationG. F. Proklova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: rtchilova@gmail.com
ORCID iD: 0000-0003-3382-026X
Candidate of Medical Sciences
Russian FederationT. G. Manucheva
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: rtchilova@gmail.com
ORCID iD: 0009-0003-8907-1090
Russian Federation
Z. M. Kokhreidze
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: rtchilova@gmail.com
ORCID iD: 0009-0004-4339-2558
Russian Federation
G. E. Sevastyanov
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: rtchilova@gmail.com
ORCID iD: 0009-0000-4823-9510
Russian Federation
References
- Mas A., Tarazona M., Dasi Carrasco J. et al. Updated approaches for management of uterine fibroids. Int J Womens Health. 2017; 9: 607–17. doi: 10.2147/IJWH.S138982
- Gurusamy K.S., Vaughan J., Fraser I.S. et al. Medical Therapies for Uterine Fibroids – A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. PLoS One. 2016; 11 (2): e0149631. doi: 10.1371/journal.pone.0149631
- Lee S.M., Choi E.S., Ha E. et al. Gyejibongnyeong-Hwan (Gui Zhi Fu Ling Wan) Ameliorates Human Uterine Myomas Via Apoptosis. Front Pharmacol. 2019; 10: 1105. doi: 10.3389/fphar.2019.01105
- Verpalen I.M., Anneveldt K.J., Nijholt I.M. et al. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis. Eur J Radiol. 2019; 120: 108700. doi: 10.1016/j.ejrad.2019.108700
- Liu L., Wang T., Lei B. High-intensity focused ultrasound (HIFU) ablation versus surgical interventions for the treatment of symptomatic uterine fibroids: a meta-analysis. Eur Radiol. 2022; 32 (2): 1195–204. doi: 10.1007/s00330-021-08156-6
- Liu L., Wang T., Lei B. Ultrasound-guided Microwave Ablation in the Management of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2021; 28 (12): 1982–92. doi: 10.1016/j.jmig.2021.06.020
- Liu L., Wang T., Lei B. Uterine Artery Embolization Compared with High-intensity Focused Ultrasound Ablation for the Treatment of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2021; 28 (2): 218–27. doi: 10.1016/j.jmig.2020.11.004
- Li F., Chen J., Yin L. et al. HIFU as an alternative modality for patients with uterine fibroids who require fertility-sparing treatment. Int J Hyperthermia. 2023; 40 (1): 2155077. doi: 10.1080/02656736.2022.2155077
- Kohi M.P., Spies J.B. Updates on Uterine Artery Embolization. Semin Intervent Radiol. 2018; 35 (1): 48–55. doi: 10.1055/s-0038-1636521
- Donnez J., Donnez O., Dolmans M.M. The current place of medical therapy in uterine fibroid management. Best Pract Res Clin Obstet Gynaecol. 2018; 46: 57–65. doi: 10.1016/j.bpobgyn.2017.10.008
- Llewellyn O., Patel N.R., Mallon D. et al. Uterine Artery Embolisation for Women with Giant Versus Non-giant Uterine Fibroids: A Systematic Review and Meta-analysis. Cardiovasc Intervent Radiol. 2020; 43 (5): 684–93. doi: 10.1007/s00270-019-02359-7
- Xu F., Deng L., Zhang L. et al. The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta analysis. Int J Hyperthermia. 2021; 38 (2): 24–9. doi: 10.1080/02656736.2021.1933216
- Sandberg E.M., Tummers F.H.M.P., Cohen S.L. et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis. Fertil Steril. 2018; 109 (4): 698–707.e1. doi: 10.1016/j.fertnstert.2017.11.033
- Hussein A.M., Elbarmelgy R.A., Elbarmelgy R.M. et al. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder. Ultrasound Obstet Gynecol. 2022; 59 (4): 474–82. doi: 10.1002/uog.23732
Supplementary files
